Press Releases

RSS
  • Jul 7, 2015
    ENGLEWOOD, Colo., July 7, 2015 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare company focused on developing treatments for urological and related conditions, announced today that the company is now trading under the new symbol "AYTU," following its corporate name change, which became effective June 8, 2015. All stock trading, filings, and market related information wi...
    Jun 9, 2015
    ENGLEWOOD, Colo., June 9, 2015 /PRNewswire/ -- Aytu BioScience, Inc. (OTCMKTS: RSWN), a specialty healthcare company focused on developing treatments for urological and related conditions, today entered into an agreement with Jazz Pharmaceuticals (NASDAQ: JAZZ) to acquire Jazz Pharmaceuticals' rights to ProstaScint®, an imaging agent used to detect the extent and spread of prostate cancer that i...
    Jun 2, 2015
    ENGLEWOOD, Colo., June 2, 2015 /PRNewswire/ -- Rosewind Corporation (OTCQB: RSWN) announced that, after necessary state filings, the company will be known as Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions.  The corporate name change was approved by shareholders at a special meeting of Rosewind Corp. shareholders held o...
    May 18, 2015
    The Rosewind presentation is scheduled to start at 3:00 p.m. EDT on Thursday, May 28, 2015. A live audio webcast of the presentation will be available online at Rosewind's Investors web page: http://aytubio.com/investors.  ...
    Apr 16, 2015
    LOVELAND, Colo., April 16, 2015 /PRNewswire/ -- Rosewind Corporation (OTCMKTS: RSWN) announced today that it has completed a reverse merger with a newly formed specialty healthcare company focused on redox-modulated conditions, with an initial focus on addressing urological disorders. The merged company, which is expected to be re-named Aytu BioScience Inc., has commenced operations and incorpora...